Yes, why do they put this article out 3 days before PDUFA? This data has been known by the company, COSMO, public and FDA for a long time. COSMO took SNTS shares in lieu of cash on completion of Phase III trial. Also, FDA could have already given them CRL or refusal to file to begin with. Why would they issue proposed labeling ahead of PDUFA? Makes no sense if CRL were coming.